References
- Anthony J. C., Petronis K. R. Early onset drug use and risk of later drug problems. Drug and Alcohol Dependence 1995; 40: 9–15
- Barrett B., Byford S., Crawford M. J., Patton R., Drummond C., Henry J. A., et al. Cost-effectiveness of screening and referral to an alcohol health worker in alcohol misusing patients attending an accident and emergency department: a decision-making approach. Drug and Alcohol Dependence 2006; 81: 47–54
- Bellis M. A., Hughes K., Lowey H. Healthy nightclubs and recreational substance use: from a harm minimisation to a healthy settings approach. Addictive Behaviors 2002; 27: 1025–1035
- Crawford M. J., Patton R., Touquet R., Drummond C., Byford S., Barrett B., et al. Screening and referral for brief intervention of alcohol-misusing patients in an emergency department: a pragmatic randomised controlled trial. Lancet 2004; 364: 1334–1339
- Jammer M. S., Wolitski R. J., Corby N. H. Impact of a community HIV intervention targeting injecting drug users' stage of change for condom and bleach use. American Journal of Health Promotion 1997; 12: 15–24
- London Drugs Policy Forum and Home Office. Safer clubbing. 2002, Retrieved May 21, 2008, from http://www.cityoflondon.gov.uk/NR/rdonlyres/C9C2A52B-D729-4896-A27C-BB99271AFA0A/0/safer_clubbing.pdf
- Marsden J., Stillwell G., Barlow H., Boys A., Taylor C., Hunt N., et al. An evaluation of a brief motivational intervention among young ecstasy and cocaine users: no effect on substance and alcohol use outcomes. Addiction 2006; 101: 1014–1026
- McCambridge J., Mitcheson L., Winstock A., Hunt N. Five-year trends in patterns of drug use among people who use stimulants in dance contexts in the United Kingdom. Addiction 2005; 100: 1140–1149
- McCambridge J., Winstock A., Hunt N., Mitcheson L. Five-year trends in use of hallucinogens and other adjunct drugs among UK dance drug users. European Addiction Research 2007; 13: 57–64
- Medical Despatch Company Profile. 2008, Retrieved May 21, 2008, from http://www.medicaldespatch.co.uk/co.htm
- Staack R. F. Piperazine designer drugs of abuse. Lancet 2007; 369: 1411–1413
- United Nations Office on Drugs and Crime. World Drug Report 2007. 2007, Retrieved May 20, 2008, from http://www.unodc.org/pdf/research/wdr07/WDR_2007.pdf
- Vitale S., van de Mheen D. Illicit drug use and injuries: A review of emergency room studies. Drug and Alcohol Dependence 2006; 82: 1–9
- White B., Degenhardt L., Breen C., Bruno R., Newman J., Proudfoot P. Risk and benefit perceptions of party drug use. Addictive Behaviors 2006; 31: 137–142
- Wood D. M., Bishop C., Greene S., Dargan P. I. Ketamine-related toxicology presentations to the ED. Clinical Toxicology 2008; 46: 630
- Wood D. M., Button J., Ashraf T., Walker S., Greene S. L., Ramsey J., et al. What evidence is there that the UK should tackle the potential emerging threat of methamphetamine toxicity rather than established recreational drugs such as MDMA (‘Ecstasy’)?. Quarterly Journal of Medicine 2008; 101: 207–213
- Wood D. M., Greene S. L., Alldus G., Huggett D., Nicolaou M., Chapman K., et al. Improvement in the pre-hospital care of recreational drug users through the development of club specific ambulance referral guidelines. Substance Abuse Treatment, Prevention, and Policy 2008; 3: 14
- Wood D. M., Warren-Gash C., Ashraf T., Greene S. L., Shather Z., Trivedy C., et al. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD). Quarterly Journal of Medicine 2008; 101: 23–29